Introduction
A significant proportion of patients undergoing invasive coronary angiography (ICA) due to stable chest pain do not have obstructive epicardial coronary artery disease (CAD). 1 With these individuals, primary coronary microvascular dysfunction (CMD) can be an underlying cause in ischaemia and angina pectoris. [2] [3] [4] Coronary microvascular abnormalities demonstrated by intra-coronary provocative testing are present in considerable proportion of patients who suffer from chest pain and non-obstructive coronary atherosclerosis. [5] [6] [7] [8] However, invasive tests of microvascular function are not commonly used in clinical practice and the prevalence of CMD in a typical population referred to non-invasive diagnostic testing due to stable chest pain and suspected CAD is uncertain. Detection of CMD by non-invasive testing is challenging. Findings of exercise electrocardiography (ECG), stress echocardiography, and conventional nuclear imaging are poor predictors of CMD. [7] [8] [9] The main non-invasive feature of CMD is diffuse reduction in absolute myocardial blood flow (MBF) in response to vasodilator stress or reduced coronary flow reserve (CFR) as assessed by positron emission tomography (PET) perfusion imaging. 3, 10 However, because obstructive CAD and microvascular dysfunction often co-exist, discrimination between their effects on MBF is difficult based on perfusion imaging alone. 3, 10 Recently, it has become possible to combine the assessment of absolute MBF with evaluation of coronary anatomy by non-invasive coronary computed tomography angiography (CCTA) using a hybrid PET/CT scanner. [11] [12] [13] Previous studies have demonstrated that hybrid imaging is an accurate method in the detection of significant, obstructive CAD, [11] [12] [13] but its value in the assessment of CMD has not been studied in detail. We wanted to prospectively study the frequency and angiographic characteristics of CMD identified as abnormal response to vasodilator stress by PET perfusion imaging in patients with stable chest pain and intermediate pre-test probability of obstructive CAD. Epicardial coronary anatomy was studied by CCTA using a hybrid PET/CT scanner. Per study protocol, patients also underwent ICA combined with measurement of fractional flow reserve (FFR) when indicated to exclude haemodynamically significant obstructive epicardial CAD in patients with suspected CMD.
Methods Patients
We recruited prospectively 189 outpatients during 2007-2011 in Turku University Hospital. Consecutive patients with stable chest pain or equivalent symptom and intermediate pre-test probability (20-90%) of obstructive CAD were considered for inclusion. The assessment of the pre-test probability of CAD was based on age, sex, type of chest pain, and the result of the exercise ECG (exercise ECG was not mandatory, but performed in 184 patients). 2, 14 Patients with previous angiographically proven CAD, previous known myocardial infarction, acute coronary syndrome, significant valvular disease, congestive heart failure, left ventricular systolic dysfunction, contraindication to CCTA (atrial fibrillation, iodine allergy, severe loss of renal function, pregnancy) or contraindication to adenosine were not considered. The study was approved by the local ethics committee of the Hospital District of Southwest Finland and was conducted according to the guidelines of the Declaration of Helsinki. Informed consent was collected from all patients. The trial has been registered prospectively in a publically accessible database (http://www.clinicaltrials.gov. Unique identifier: NCT00627172).
Study design and data collection
The study protocol included CCTA and myocardial PET perfusion imaging with PET/CT hybrid scanner, and ICA on average 29 days (range 2-178 days) after the first imaging study. No cardiac events took place between PET/CT and ICA. Eleven patients in whom PET study failed were excluded from the final study population (n = 189). One patient in whom CCTA was non-diagnostic due to motion artefacts, but ICA showed significant three-vessel disease, was included. Eleven patients (10 with normal CCTA and 1 with non-obstructive atherosclerosis in the LAD) refused to undergo ICA, but were included.
Data on risk factors for CAD (smoking, prediabetes, diabetes, hypertension, dyslipidaemia, and family history of CAD), type of symptoms (typical angina, atypical angina, non-anginal chest pain, or angina equivalent), exercise ECG findings, and medication were obtained from questionnaires or electronic hospital medical records. Authors had direct access to all data. Prediabetes was defined as impaired fasting plasma glucose levels (6.1-6.9 mmol/L), impaired glucose tolerance (2 h plasma glucose 7.8-11.0 mmol/L in a 75 g oral glucose tolerance test), or blood haemoglobin A1c 6.0-6.4%.
Hybrid PET/CT imaging
Patients were scanned with a 64-row PET/CT scanner (GE Discovery VCT, General Electric Medical Systems, Waukesha, WI, USA) as previously described. 12, 15 Briefly, before CCTA, patients received 800 lg of sublingual nitrate and intravenous metoprolol up to 30 mg in order to achieve target heart rate < 60 bpm. Coronary calcium score (CCS) was first assessed (Agatston method). Then, CCTA was performed after infusion of low-osmolal iodine contrast agent (50-96 mL of 350-400 mg iodine/mL iomeprol, iohexol, or iobitridol). The collimation was 64 Â 0.625 mm, gantry rotation time was 350 ms, tube current was 600-750 mA, and voltage was 100-120 kV, depending on patient size. Prospectively triggered acquisition was used whenever possible in order to reduce radiation dose. The radiation exposure of CCTA varied between 2 and 8 mSv. The presence of non-obstructive and obstructive atherosclerosis was analysed by an experienced reader blinded to clinical data.
Rest-stress myocardial perfusion imaging with PET using 15 O-labeled water was performed immediately after CCTA as described earlier. 12, 15 Briefly, the patients were instructed to avoid coffee and any caffeine containing beverages for a minimum of 12 h before the scan. If this could not be verified at a pre-screening interview, PET perfusion imaging was performed on a separate session another day (6 patients, range 4-25 days). O-water radioactivity, a stress scan was performed during adenosine infusion that was started 2 min before scan and infused until the end of the scan at 140 lg/kg/min. Alignment of PET images and CT images used for attenuation correction was confirmed visually and images were reconstructed using the two-dimensional OSEM algorithm. The mean radiation dose of the perfusion studies was 1 mSv. Coronary vascular resistance was calculated as mean arterial pressure (MAP) divided by global MBF and mean of the 3 and 6 min systolic and diastolic blood pressure measurements after adenosine administration were used to calculate MAP.
An experienced reader analysed regional MBF with Carimas software blinded to other results and clinical data as described earlier. 12, 15 Fusion images were created to match regional myocardial perfusion with individual coronary anatomy based on CCTA. CFR was calculated as the ratio of stress-to-rest MBF in each region.
ICA and FFR
Coronary angiograms were performed on Siemens Axiom Artis coronary angiography system (Siemens, Erlangen, Germany) as described earlier. 12, 15 Measurement of FFR was performed for stenoses with intermediate severity (30-80%) when feasible using ComboMap pressure/flow instrument and a 0.014 inch BrightWire pressure guidewires (Volcano Corp, Rancho Cordova, CA, USA). The pressure was measured distally to the lesion during maximal hyperaemia induced by 18 lg intracoronary boluses of adenosine with simultaneous measurement of aortic pressure. FFR was calculated as the ratio between the mean distal pressure and mean aortic pressure. Quantitative analysis of coronary angiograms was performed using software with automated edge detection system (Quantcore, Siemens, Munich, Germany) by an experienced reader blinded to the results of PET, CCTA, and FFR. 
Definitions and interpretation of imaging results
We defined CMD as diffusely abnormal absolute MBF during adenosine stress in myocardial regions supplied by the main coronary arteries [left anterior descending artery (LAD), left circumflex artery (LCx), and right coronary artery (RCA)] in the absence of corresponding epicardial obstructive CAD. Significant obstructive CAD was defined as either > _ 50% stenosis on ICA or FFR < 0.8. When FFR was available, stenoses with FFR > _ 0.8 were classified as non-significant, regardless of the degree of coronary narrowing. The threshold for abnormal stress MBF was < 2.4 mL/g/min based on previous validation. 15 Non-obstructive atherosclerosis was defined as the presence of coronary calcium or atherosclerotic plaque on CCTA in the absence of significant obstructive CAD on ICA. 
Statistical methods

Results
Clinical characteristics of the 189 patients are summarized in Table 1 .
Mean age was 62 years, 55% of the patients were men and risk factors for CAD were common. The most common symptom was atypical angina pectoris or non-anginal chest pain (in 50%) followed by typical angina pectoris (in 37%). Average pre-test probability of CAD was 65%. Based on CCTA and ICA, 43 patients (23% of all patients) had normal coronary arteries, 76 (40%) had non-obstructive atherosclerosis, and 70 (37%) had obstructive CAD. Of the patients with obstructive CAD, 40% had one-vessel, 23% two-vessel, and 37% three-vessel disease.
Prevalence of CMD
As illustrated in Figure 1 , absolute MBF during adenosine stress was normal (> _2.4 mL/g/min) in the myocardium supplied by the LAD, LCX, and RCA in 119 (63%) of patients. Regional abnormalities in stress MBF consistent with regional ischaemia caused by epicardial coronary stenosis were observed in 38 (20%) patients.
Absolute MBF during vasodilator stress was diffusely abnormal (<2.4 mL/g/min) in the myocardium supplied by all major coronary arteries in 32 (17%) patients. In 15 (8% of all patients) of these, reduced MBF was explained by obstructive three-vessel CAD and was suggestive of balanced ischaemia. In 17 (9% of all patients) patients, diffuse abnormality of stress MBF was not explained by epicardial obstructive CAD and these patients were diagnosed with CMD. Two representative cases are shown in Figures 2 and 3 .
Coronary anatomy in patients with CMD
Coronary angiography findings in 17 patients with CMD are described in Table 2 . Only two patients (1% of all patients) had CMD in the presence of normal epicardial coronary anatomy (coronary calcium score = 0, no atherosclerosis on CCTA). Five patients (3% of all patients) had CMD associated with non-obstructive atherosclerosis. Ten patients (5% of all patients) had co-existing CMD and obstructive CAD, i.e. diffusely abnormal stress MBF was not explained by the presence of obstructive CAD alone based on fusion of perfusion maps with individual coronary anatomy. Of these, three had one-vessel disease and seven had two-vessel disease.
Clinical characteristics, risk factors, medications, and CMD
Clinical characteristics, CAD risk factors, and medications are compared between patients with and without CMD in Table 1 . Presenting symptoms showed similar distribution in patients with and without CMD. The patients with CMD were more commonly male than patients without CMD, but there were no differences in number of smokers or prevalence of prediabetes, diabetes, hypertension, Figure 1 Prevalence of coronary microvascular dysfunction (CMD) based on myocardial perfusion imaging and coronary angiography. CMD was defined as diffusely abnormal perfusion (myocardial blood flow < 2.4 mL/g/min within regions of three main coronary arteries) that was not explained by obstructive epicardial coronary artery disease (CAD). The results are shown as numbers (n) and percentages from all patients. Figure 2 Coronary microvascular dysfunction in the absence of atherosclerosis in a 58-year-old man with atypical angina pectoris, history of smoking, family history of coronary artery disease, and ischaemia on exercise ECG. Myocardial blood flow (MBF) during adenosine stress was moderately reduced in all vessel areas (A, global MBF 1.9 mL/g/min). MBF at rest was homogenously distributed (B) and CFR was reduced being 2. 
Determinants of coronary haemodynamics
Absolute regional MBF values during adenosine stress in CMD patients are shown in Table 2 . In patients with CMD and normal in the regions supplied by all three main coronary arteries, whereas in patients with co-existing CMD and obstructive CAD, MBF was usually lowest within the region supplied by an obstructed coronary artery. Notably, stress MBF within the corresponding territory did not correlate with the extent of CCS in the LAD (r = -0.136, P = 0.260), LCX (r = 0.080, P = 0.506), or the RCA (r = 0.002, P = 0.989) in the absence of obstructive CAD. Mean absolute global MBF during adenosine stress was markedly lower in patients with CMD than other patients both in the absence (n = 119) and presence (n = 70) of obstructive CAD (1.90 vs. 3.96 mL/g/min, P = 0.000 and 1.53 vs. 2.67 mL/g/min, P = 0.000, respectively). Similar pattern was also seen with CFR (2.61 vs. 3.71, P = 0.001 and 1.72 vs. 2.69, P = 0.003) (Supplementary data online, Table S1 ).
Linear regression analysis was performed to assess the factors affecting coronary haemodynamics in patients without obstructive CAD (n = 119, Table 3 ). Univariate analysis showed that only female sex and presence of non-obstructive atherosclerosis significantly predicted global stress MBF, global CFR, and coronary vascular resistance. According to multivariable analysis, female sex was related to global stress MBF, global CFR and coronary vascular resistance, whereas non-obstructive atherosclerosis was related to global stress MBF.
Discussion
Coronary microvascular dysfunction identified as abnormal vasodilator capacity by PET perfusion imaging exists in 9% of patients with stable chest pain and suspected CAD. However, microvascular dysfunction without any coronary atherosclerosis is rare in this population. We studied a large prospective cohort of symptomatic patients with intermediate pre-test probability of CAD that is the typical population referred for non-invasive ischaemia testing. In addition, coronary anatomy was evaluated by angiography to detect CMD.
The main finding in the present study is that CMD is relatively rare in the absence of obstructive CAD in symptomatic population with suspected stable CAD. Only 1% of patients had CMD without any coronary atherosclerosis and 4% had CMD in the presence of nonobstructed coronary arteries. Previous studies demonstrated CMD detected as abnormal response to intracoronary adenosine in 24% or intracoronary acetylcholine in 19-24% of patients with nonobstructed coronary arteries undergoing invasive angiography due to chest pain. 7, 8 Lower prevalence in our study may be explained by differences in patient populations since the patients in the current study had typically low-intermediate pre-test probability of CAD and patients with previous history of diabetes, obstructive CAD, myocardial infarction or acute coronary syndromes, which are associated with risk of CMD, were excluded. 7, 8, 16 Furthermore, at the time of the imaging studies many patients in our study were on medications potentially preserving vascular function, such as statin, angiotensin converting enzyme inhibitor or angiotensin receptor blocker, due to the presence of risk factors and clinical suspicion of CAD. Beta-blockers were routinely administered before CCTA, but their effects on coronary vascular function remain controversial. Frequency and angiographic characteristics of coronary microvascular dysfunction independent mechanisms and thus, some patients with isolated endothelial dysfunction presenting as abnormal blood flow response to acetylcholine may have been missed. 8 Another finding in our study is that CMD is closely associated with the presence of epicardial coronary atherosclerosis in symptomatic patients with suspected CAD. The presence of coronary atherosclerosis predicted reduced global stress MBF and of patients with CMD, 88% had evidence of coronary atherosclerosis with 59% having CMD co-existing with obstructive CAD. These findings are in line with previous observations showing association between CFR and the amount of coronary calcium. 19 Our results are also consistent with previous observations showing discordance between measures of myocardial or coronary blood flow and either FFR or anatomical severity of intermediate epicardial stenosis. 10, [20] [21] [22] [23] CMD can contribute to ischaemia and angina in these patients with non-obstructive or obstructive CAD. Some studies have indicated that CMD can manifest as regional perfusion abnormality. [24] [25] [26] In our study, four patients with coronary atherosclerosis had regional perfusion defect without significant stenosis in this area, but the extent of coronary calcium did not correlate with regional stress MBF.
Our results suggest that non-invasive hybrid PET/CT imaging can be useful for identification of CMD, because obstructive CAD can be excluded by CCTA in patients with suspected microvascular dysfunction identified as diffusely reduced stress MBF. Previous studies have shown that diffusely diminished CFR by PET perfusion imaging is common finding and provides important prognostic information on mortality and adverse cardiac events independently of regional ischaemia, [27] [28] [29] or coronary calcium. 30 Without coronary angiography it is difficult to differentiate contributions of obstructive CAD and CMD to reduced CFR. In line with previous studies, 31,32 diffusely reduced stress MBF was often attributed to three-vessel obstructive CAD in our study. We chose a cut-off value (<2.4 mL/g/min) of abnormal stress MBF that has been previously validated against FFR in patients with epicardial stenosis. 15 The optimal cut-off values may vary depending on the technique, 3, 4, 26, 27 for instance studies have reported that hyperaemic MBF of 1.85 mL/g/min with 13 N-ammonia PET and CFR of 1.74 with 82 Rb PET are optimal thresholds for the detection of significant coronary stenosis or ischaemia. 33, 34 Microvascular dysfunction has been associated with atherosclerotic risk factors. 3, 4 In our patient population, these risk factors were common, but did not differ between CMD and other patients and were not significantly associated with global stress MBF, CFR, or coronary vascular resistance. However, associations between CMD and risk factors of CAD may be confounded by selecting only symptomatic patients. In line with some recent studies, 6, 7, 8, 27 we also found that CMD was prevalent in both women and men. Limitations of the study include that we did not have a control group of patients without chest pain and therefore we are unable to compare prevalence of microvascular dysfunction in symptomatic patients and general population. We are unable to compare CMD detected by non-invasive MBF and invasive tests since this study did not include invasive assessment of microvascular dysfunction. Currently, we do not have follow-up data on clinical outcomes and probably, a larger population would be needed to assess prognostic value of CMD. Hybrid PET/CT imaging probably enables studying prognostic implications of coronary atherosclerosis and vascular dysfunction in more detail.
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